» Articles » PMID: 39060536

Multiple Craniotomies in Patients with Brain Metastases: a Two-center, Propensity Score-matched Study

Overview
Journal Neurosurg Rev
Specialty Neurosurgery
Date 2024 Jul 26
PMID 39060536
Authors
Affiliations
Soon will be listed here.
Abstract

The current study addresses the question of whether the resection of more than one BM by multiple craniotomies within the same operation is associated with more adverse events (AEs) and worse functional outcome compared to cases in which only one BM was resected. All patients who underwent more than one craniotomy for resection of multiple BM at two Swiss tertiary neurosurgical care centers were included. Any AEs, functional outcome, and overall survival (OS) were analyzed after 1:1 propensity score matching with patients who underwent removal of a single BM only. A total of 94 patients were included in the final study cohort (47 of whom underwent multiple craniotomies). There was no significant difference in the incidence of AEs between the single and the multiple craniotomy group (n = 2 (4.3%) vs. n = 4 (8.5%), p = .7). Change in modified Rankin Scale (mRS) and Karnofsky Performance Status (KPS) at discharge demonstrated that slightly more single craniotomy patients improved in mRS, while the proportion of patients who worsened in mRS (16.3 vs. 16.7%) and KPS (13.6 vs. 15.2%) was similar in both groups (p = .42 for mRS and p = .92 for KPS). Survival analysis showed no significant differences in OS between patients with single and multiple craniotomies (p = .18). Resection of multiple BM with more than one craniotomy may be considered a safe option without increased AEs or worse functional outcome.

Citing Articles

Comment on: Multiple craniotomies in a single surgery - the resection of scattered brain metastases.

Meghwar S, Singh A, Kumar S Neurosurg Rev. 2024; 47(1):575.

PMID: 39245784 DOI: 10.1007/s10143-024-02809-y.

References
1.
Brastianos P, Carter S, Santagata S, Cahill D, Taylor-Weiner A, Jones R . Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov. 2015; 5(11):1164-1177. PMC: 4916970. DOI: 10.1158/2159-8290.CD-15-0369. View

2.
Ng P, Choi B, Aghi M, Nahed B . Surgical advances in the management of brain metastases. Neurooncol Adv. 2021; 3(Suppl 5):v4-v15. PMC: 8633760. DOI: 10.1093/noajnl/vdab130. View

3.
Bindal R, Sawaya R, LEAVENS M, Lee J . Surgical treatment of multiple brain metastases. J Neurosurg. 1993; 79(2):210-6. DOI: 10.3171/jns.1993.79.2.0210. View

4.
Hazuka M, Burleson W, Stroud D, Leonard C, Lillehei K, Kinzie J . Multiple brain metastases are associated with poor survival in patients treated with surgery and radiotherapy. J Clin Oncol. 1993; 11(2):369-73. DOI: 10.1200/JCO.1993.11.2.369. View

5.
Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F . EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol. 2021; 32(11):1332-1347. DOI: 10.1016/j.annonc.2021.07.016. View